Navigation Links
Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets
Date:1/28/2016

NEW YORK, Jan. 28, 2016 /PRNewswire/ -- This BCC Research report provides an in-depth study of the liquid biopsy diagnostics industry. The global market is analyzed by application, biomarker type, analysis platform, analysis purpose and geographic region. The market sizes are given for the years 2014, 2015 and 2020.

Use this report to:
Analyze the market for liquid biopsy diagnostics in depth.
Gain information on liquid biopsy technologies, clinical applications, industry structure, important liquid biopsy funding initiatives, global markets, patent status and companies.
Learn about some of the top research initiatives that are contributing to liquid biopsy development.
Gain information on various liquid biopsy diagnostics markets, including for reproductive health, cancer and transplant diagnostics

Highlights

The global liquid biopsy market should reach nearly $4.5 billion in 2020 from $1.6 billion in 2015, registering a CAGR of 22.3% for the period of 2015-2020.
The cancer application market will increase at a CAGR of 36.2% over the forecast period to grow from $414.5 million in 2015 to $1.9 billion in 2020.
The non-cancer application market as a segment reached $1.2 billion in 2015 and should reach $2.5 billion by 2020 increasing at a CAGR of 15.7%.


STUDY GOALS AND OBJECTIVES

This BCC Research report provides an in-depth study of the liquid biopsy diagnostics industry, an emerging industry with high market potential. The global market is analyzed by application, biomarker type, analysis platform, analysis purpose and geographic region. The market sizes are given for the years 2014, 2015 and 2020.
Market segments that provide exceptional growth opportunities include cancer monitoring and organ transplant surveillance.

The report provides a comprehensive discussion of liquid biopsy technologies, clinical applications, industry structure, important liquid biopsy funding initiatives, global markets, patent status and companies. The report is designed to aid companies in their strategic planning efforts relating to life science tools and diagnostics

REASONS FOR DOING THE STUDY

Traditional biopsy methods are often invasive and uncomfortable, and carry risks of side effects. Liquid biopsy addresses these issues because it is noninvasive and carries little, if any, side effect risks.

With the advent of the age of genomics and personalized medicine, it is critical for clinicians to have diagnostic tools that can be used on a regular basis to monitor, conduct surveillance, guide treatment or otherwise give valuable genomic information about a disease. Liquid biopsy provides this capability, and thus is of high interest to the medical community.

Liquid biopsy enabling technologies are rapidly making progress, and this is adding to the market growth momentum. Downstream analysis technologies like next-generation sequencing (NGS) and digital polymerase chain reaction (PCR) are progressing in capabilities, efficiency and costs. Upstream technologies like icrofluidics, cell capture and DNA amplification are also making significant progress.

Based on these trends, liquid biopsy markets are rapidly emerging, and the need for industry and market characterization is great.

Also, liquid biopsy is extending its market penetration into high-volume diagnostics segments, including average risk noninvasive prenatal testing (NIPT) and cancer monitoring.

The outstanding growth potential for liquid biopsy diagnostics makes it particularly timely for doing this report.

Read the full report: http://www.reportlinker.com/p03596607-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001


'/>"/>
SOURCE Reportlinker
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Global Liquid Biopsy Markets Market Report 2016-2020 - Blood Tests Replace Surgical Biopsies / Single Screening Test for all Cancers Announced
2. Therapy Monitoring Emerges as a Promising Application for Liquid Biopsy
3. Global Prenatal & Maternal Diagnostic Market Analysis to 2020: Molecular Diagnostics, Liquid Biopsy, Personalized Medicine Diagnostics & In vitro Diagnostics (IVD) Markets
4. Caris Life Sciences Non-Invasive Liquid Biopsy Platform ADAPT Biotargeting System Demonstrates Potential to Improve Accuracy of Breast Cancer Diagnosis
5. Liquid Biopsy Market Growth Forecast at 30%+ CAGR to 2019
6. Sequenom Collaborates With University Medical Center Hamburg-Eppendorf To Evaluate Clinical Utility Of Liquid Biopsy In Colorectal Cancer
7. Practical Clinical Benefits of Trovagenes Urine-Based Liquid Biopsy Platform Demonstrated in Field Experience Analysis
8. Liquidia Technologies and GlaxoSmithKline Advance Existing Collaboration; GlaxoSmithKline Exercises Option for Inhaled Therapeutics
9. Pathway Genomics Launches First Liquid Biopsy Test To Detect Cancer-Associated Mutations In High-Risk Patients
10. Trovagenes Urine-Based Liquid Biopsy Platform Shown to Detect Impact of Cancer Therapy within 24 Hours
11. Breast Cancer Liquid Biopsy Results Presented At World CDx Conference In Boston
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/14/2019)... ... 13, 2019 , ... Corey Stern , a partner at Levy Konigsberg, ... Archibald over at least 3 decades while employed by Rockefeller University Hospital (“RUH”). ... Court - Southern District of New York, No. 1:19-cv-01403), the first case filed against ...
(Date:9/14/2019)... N.J. (PRWEB) , ... September 14, 2019 , ... ... trial of four plaintiffs living with peritoneal mesothelioma, a jury in Middlesex County ... first consolidated trial of plaintiffs alleging their mesotheliomas were caused by asbestos-containing J&J ...
(Date:9/11/2019)... China (PRWEB) , ... September ... ... Co., Ltd.“Jiuzhou Pharmaceutical, a world leading Active Pharmaceutical Ingredients (API) contract development ... commitment for the purchase of Suzhou Novartis Pharmaceutical Technology Ltd (SNPT), an ...
Breaking Medicine Technology:
(Date:9/11/2019)... ... 11, 2019 , ... A September 2 article on CBS News ... significantly less likely to suffer heart attacks, strokes, kidney failure, and heart disease versus ... weight loss surgery specialists Dr. Feiz and Associates says the study adds further evidence ...
(Date:9/11/2019)... ... September 11, 2019 , ... GRM Information ... AHIMA Health Data and Information Conference in Chicago, Illinois September 14 to 18. ... learn more about GRM’s healthcare information management solutions . , Built around ...
(Date:9/11/2019)... ... September 11, 2019 , ... PatientPay, the ... healthcare, announces the issuance of a patent to reduce the level of effort ... both time-of-service and post visit patient statements. , At the core of “Instant ...
(Date:9/11/2019)... ROYAL OAK, Mich. (PRWEB) , ... September 10, 2019 , ... ... location. The new office is location at 32686 Woodward Ave, Suite 103, Royal ... 14 mile. , “Our Royal Oak location offers comprehensive women’s health services in a ...
(Date:9/11/2019)... ... September 10, 2019 , ... ... to explore solutions to problems facing the ever-changing corporate landscape, Mediaplanet today ... “Employee Benefits and Engagement.” With topics ranging from the importance of candid ...
Breaking Medicine News(10 mins):